Effects of activation and inhibition of cAMP-dependent protein kinase on long-term habituation in the crab Chasmagnathus

Brain Res. 1996 Sep 30;735(1):131-40. doi: 10.1016/0006-8993(96)00584-7.

Abstract

On sudden presentation of a danger stimulus, the crab Chasmagnathus elicits an escape response that habituates promptly and for a long period. We have previously reported that administration of a cAMP-permeable analog (CPT-cAMP) along with a phosphodiesterase inhibitor (IBMX) improves long-term habituation (LTH). In present experiments we studied the effect of systemic administration of the protein kinase A (PKA) activator Sp-5,6-DCl-cBIMPS and that of the PKA inhibitor Rp-8-Cl-cAMPS on LTH tested 24 h after a weak training protocol (5 trials of danger stimulus presentation) or a strong training protocol (15-30 trials), respectively. A 50 microliters pre-training injection of 75 microM Sp-5,6-DCl-cBIMPS, and to a lesser degree of 25 microM, improved retention of the habituated response but not affect short-term habituation (STH). Like pre-training injection, post-training administration of Sp-5,6-DCl-cBIMPS proved to exert a facilitatory action on retention though with 75 microM dose only. Conversely, both pre- and post-training injection of 25 microM Rp-8-Cl-cAMPS impaired LTH without affecting STH. Thus, the PKA activator Sp-5,6-DCl-cBIMPS enables a weak training to produce LTH while the PKA inhibitor Rp-8-Cl-cAMPS impairs LTH when a strong training is given. Activation of crab PKA by Sp-5,6-DCl-cBIMPS and its inhibition by Rp-8-Cl-cAMPS were assessed using an in vitro PKA activity assay. These results provide independent evidences supporting the view that PKA plays a key role in long-term memory storage in this learning paradigm.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amnesia / chemically induced
  • Animals
  • Antineoplastic Agents / pharmacology
  • Brachyura
  • Brain Chemistry
  • Conditioning, Psychological / drug effects
  • Cyclic AMP / analogs & derivatives
  • Cyclic AMP / pharmacology
  • Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors*
  • Cyclic AMP-Dependent Protein Kinases / metabolism*
  • Dichlororibofuranosylbenzimidazole / analogs & derivatives
  • Dichlororibofuranosylbenzimidazole / pharmacology
  • Ganglia, Invertebrate / chemistry
  • Habituation, Psychophysiologic / drug effects*
  • Habituation, Psychophysiologic / physiology*
  • Male
  • Memory / drug effects
  • Thionucleotides / pharmacology

Substances

  • Antineoplastic Agents
  • Thionucleotides
  • 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole-3',5'-monophosphorothioate
  • 8-chloroadenosine-3',5'-cyclic monophosphorothioate
  • Dichlororibofuranosylbenzimidazole
  • Cyclic AMP
  • Cyclic AMP-Dependent Protein Kinases